Sphenopalatine Ganglion Block to Treat Shoulder Pain During and/or After Cesarean
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The purpose of this open label pilot study is to evaluate the utility of sphenopalatine ganglion (SPG) block to manage ipsilateral shoulder pain (ISP) during and/or after cesarean.
Condition or disease
Ipsilateral Shoulder Pain
Procedure: Transnasal SPG block
Shoulder pain thought to be caused by blood and amniotic fluid irritation of the diaphragm and nerves that supply the shoulder, can occur during and/or after a cesarean. Investigators will consent 100 patients, and will enroll 10 patients who develop ISP and have a score of is >5/10 on the Verbal Analog pain Scale (VAS). Patients will be their own controls. Transnasal SPG block will be performed after childbirth, and and beginning at 20 minutes post treatment, the patient will be asked to rate their shoulder pain using the VAS a number of times.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Presence of post-operative ISP, VAS >5/10
American Society of Anesthesiologists Class 1 - 3.
No allergy to lidocaine
American Society of Anesthesiologists Class 4 or 5.
Allergy to lidocaine
Nasal pathology (e.g., deviated septum)
Patients who receive sedatives during cesarean
Any patient who the PI feels will be unable to comply with all protocol related procedures